» Articles » PMID: 36006249

Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa

Overview
Date 2022 Aug 25
PMID 36006249
Authors
Affiliations
Soon will be listed here.
Abstract

There is an increasing attention to the emerging health problem represented by the clinical and functional long-term consequences of SARS-CoV-2 infection, referred to as postacute COVID-19 syndrome. Clinical, radiographic, and autopsy findings have shown that a high rate of fibrosis and restriction of lung function are present in patients who have recovered from COVID-19. Patients with active TB, or those who have recovered from it, have fibrotic scarred lungs and, consequently, some degree of impaired respiratory function. Helminth infections trigger predominantly type 2 immune responses and the release of regulatory and fibrogenic cytokines, such as TGF-β. Here, we analyze the possible consequences of the overlapping of pulmonary fibrosis secondary to COVID-19 and tuberculosis in the setting of sub-Saharan Africa, the region of the world with the highest prevalence of helminth infection.

Citing Articles

The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review.

Al-Kuraishy H, Al-Gareeb A, Alkazmi L, El-Bouseary M, Hamad R, Abdelhamid M J Immunol Res. 2023; 2023:5544819.

PMID: 37383608 PMC: 10299886. DOI: 10.1155/2023/5544819.


COVID-19: Current Status and Future Prospects.

Leggat P, Frean J, Blumberg L Trop Med Infect Dis. 2023; 8(2).

PMID: 36828510 PMC: 9966066. DOI: 10.3390/tropicalmed8020094.


Pneumonia Associated with COVID-19 in Patients with Interstitial Pneumonia.

Takahashi T, Saito A, Kuronuma K, Nishikiori H, Chiba H Medicina (Kaunas). 2022; 58(9).

PMID: 36143828 PMC: 9505825. DOI: 10.3390/medicina58091151.

References
1.
Wang Y, Wang Y, Chen Y, Qin Q . Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020; 92(6):568-576. PMC: 7228347. DOI: 10.1002/jmv.25748. View

2.
Udwadia Z, Vora A, Tripathi A, Malu K, Lange C, Sara Raju R . COVID-19 -Tuberculosis interactions: When dark forces collide. Indian J Tuberc. 2020; 67(4S):S155-S162. PMC: 7362784. DOI: 10.1016/j.ijtb.2020.07.003. View

3.
Tsenova L, Singhal A . Effects of host-directed therapies on the pathology of tuberculosis. J Pathol. 2020; 250(5):636-646. DOI: 10.1002/path.5407. View

4.
Gause W, Wynn T, Allen J . Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol. 2013; 13(8):607-14. PMC: 3789590. DOI: 10.1038/nri3476. View

5.
Liu F, Matsuura I . Inhibition of Smad antiproliferative function by CDK phosphorylation. Cell Cycle. 2004; 4(1):63-6. DOI: 10.4161/cc.4.1.1366. View